Positive EMA Scientific Advice Positions GeoVax for Expedited European Approval ATLANTA, GA - July 21, 2025 (NEWMEDIAWIRE) - ...

European Medicines Agency Supports Streamlined Development Pathway for GEO-MVA Vaccine Candidate via a Single Phase 3 Immuno-bridging Trial ATLANTA, GA - July 16, 2025 (NEWMEDIAWIRE) - GeoVax Labs, ...

Shares of GeoVax, currently working on a vaccine for mpox and smallpox, were up nearly 10% in mid-day trading on Friday. The stock has lost 47% of its value this year so far.

GeoVax Labs Inc.’s stock tumbled 20% early Tuesday, after the clinical-stage biotech said it’s entered an agreement with an institutional investor for the purchase and sale of 1.7 million ...

Single-Dose Protection Demonstrated Against Multiple SARS-CoV-2 Variants ATLANTA, GA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology ...

10,000- participant randomized Phase 2 b study will evaluate and compare GeoVax's multi-antigen, vaccine candidate to an approved vaccine against COVID-19 under BARDA's Clinical Studies Network.

ATLANTA, GA and BERLIN, Germany, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against ...

GeoVax, Inc. ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious ...

GeoVax’s product pipeline includes three ongoing clinical trials for which the funding will largely be used. How Atlanta took a leading role in Covid-19 vaccine research Atlanta, Chinese ...

GeoVax's stock (GOVX) has gained 389% in the month to date, rallying ever since the World Health Organization declared mpox a public health emergency of international concern last Wednesday.

An experimental vaccine developed by GeoVax Labs Inc , opens new tab succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study and has ...